NCHR Testimony at FDA Meeting about Duchenne Muscular Dystrophy Clinical Trial

May 18, 2017. Patients with Duchenne muscular dystrophy and their loved ones deserve the benefits of the most rigorous research available. At the same time, investing in a clinical trial requires significant time and effort, and patients ALWAYS face risks without any guarantee of benefits. Patients and families who are willing to participate in a clinical trial that has the potential to benefit many should be fully informed about the potential risks and benefits of their participation in order to make a decision that is best for them.

Read More »

NCHR Testimony at the FDA about a Vaccine for Respiratory Syncytial Virus (RSV)

May 17, 2017. We strongly urge this Advisory Committee to prioritize patient safety and urge the FDA to establish high standards for preclinical and clinical studies. Like any public health strategy, a vaccine’s risks must be weighed against its benefits. Given all the mistrust of vaccines in a substantial minority of Americans, it is especially important to determine how effective the vaccine is at preventing RSV and for how long. If the vaccine does not protect infants and young children through a vulnerable period of development or contributes to negative side effects, then the risks of this vaccine are too high. Given that there have been significant issues with past RSV vaccines, the FDA should ensure that they do not recommend this vaccine prematurely, especially for such a vulnerable population.

Read More »

NCHR Comments to EPA on Use of Lead Free Pipes

May 17, 2017. We strongly support the EPA’s efforts to establish labeling requirements and assure compliance with lead free standards for plumbing products intended for potable water systems. These regulations will help professionals, including manufacturers, distributors, and retailers, to more easily identify lead free materials and prevent the use of those that are not. Ultimately, this will reduce consumers’ exposure to lead in drinking water and help to prevent its serious, detrimental, and often irreparable health effects.

Read More »